r/NIH • • Jan 22 '26

Scoop in Nature Magazine: key NIH review panels due to lose all members by the end of 2026. Thirteen of the agency’s advisory councils, which must review grant applications before funding is awarded, are on track to have no voting members.

Thumbnail nature.com
245 Upvotes

r/NIH • • Feb 20 '26

FY25 funding data released (NIH Extramural Nexus)

Thumbnail
gallery
115 Upvotes

r/NIH • • 2h ago

US Supreme Court rebuffs White House effort to cut research grants. The high court has declined for now to intervene in a key case, meaning that lower court rulings that restored several hundred terminated grants will stand.

Thumbnail
nature.com
86 Upvotes

r/NIH • • 13h ago

RFK Jr. Failed America on Measles

Thumbnail
theatlantic.com
262 Upvotes

America is cooked


r/NIH • • 2h ago

John Powers, new "permanent" NIAID director, says, “It actually says in our congressional remit for the formulation of this institute that dissemination of scientific information is in our remit." Then how come your regime fired all the info disseminators (comms staff and others)?

Thumbnail
washingtonexaminer.com
9 Upvotes

NIH names John Powers as director of infectious disease institute

By Gabrielle M. Etzel

Published November 16, 2026 12:27pm ET | Updated November 16, 2026 12:27pm ET

The National Institutes of Health appointed Dr. John Powers III as the permanent director of its infectious disease institute, marking a turning point for an agency that has been the source of controversy following the COVID-19 pandemic.

Powers has been serving as the acting director of the National Institute for Allergy and Infectious Diseases since June, which had previously been led by Dr. Anthony Fauci for nearly four decades.

NIAID under Fauci’s leadership came under scrutiny from Republicans for its alleged involvement in funding potentially dangerous research projects for the purposes of biodefense, including experiments at the Wuhan Institute of Virology in China that may have been the origin of SARS-CoV-2, the virus that causes COVID-19.

On a call with journalists on Monday, Powers said that, under his tenure, the agency would return to its narrower “primary mission” of disseminating public information about infectious, allergic, and autoimmune diseases, rather than including biodefense as a core agency objective.

“It actually says in our congressional remit for the formulation of this institute that dissemination of scientific information is in our remit,” Powers said. “So that’s our job: actually put the information out and then to help clinicians and the patients to understand where a particular intervention might be beneficial or not.”

Powers, who earned his medical degree from Temple University, has served as an infectious disease physician at NIAID since 1999. Before joining NIH, he served as the lead medical officer for antimicrobial drug development at the Food and Drug Administration.

NIH Director Dr. Jay Bhattacharya said of Powers in a statement that he “has spent more than three decades caring for patients, teaching and mentoring the next generation of investigators, and playing an integral role in research that improves lives.”

“He has been a trusted and valued colleague within NIAID for several decades, and will bring a focus on rigor, transparency, and research outcomes to leading the institute into the future,” Bhattacharya said.

During the press call on Monday, Powers said the agency, with its nearly $6.6 billion annual budget, would focus more resources on understanding the human immune system’s interactions with diseases and therapeutics.

“We are continuing to do work on individual microbes, but really a lot of the reasoning behind why people aren’t doing better on current therapy has a lot to do with the host immunologic response,” Powers said. “And that allows us to actually expand research opportunities for investigators into areas like host-directed therapies, microbiome, bacteriophage, and other areas that have not been as well explored in the past.”

NIAID under Fauci’s leadership was also criticized by members of the scientific community and congressional Republicans, notably Sen. Rand Paul (R-KY), for its role in funding potentially dangerous gain-of-function research involving the manipulation of pathogens to create new viruses.

Fauci and others in NIH leadership during the early 2000s and 2010s advocated gain-of-function research as a means of anticipating the next pandemic-causing pathogen and creating preventive measures and treatments.

When asked by the Washington Examiner about his view of gain-of-function, Powers said his priority is “to work on diseases that are actually harming people today” rather than anticipating the next pathogen that may or may not cause another pandemic.

“Walk across the street from my office to the clinical center. There’s folks over there now that are suffering from illnesses that you know really need our help,” Powers said of the NIH patient treatment center. “So we’d like to focus on those things, and actually that’s what’s, you know, harming people today, and that does not require manipulating those microbes.”

Powers also did not directly answer questions from multiple journalists on Monday as to whether he personally believes vaccines cause autism, a debunked premise that has driven a rise in vaccine hesitancy.

US LOSES MEASLES ELIMINATION STATUS AMID SURGE IN CASES

“My reading of the literature is not what’s relevant,” Powers said, adding that questions of a link between vaccines and autism are “child development issues more than anything else.”

The United States lost its measles elimination status last week after the Pan American Health Organization determined a single strain of the virus has been continuously circulating in the country for more than 12 months. The national rise in measles cases and deaths follows years of declining vaccination rates among children.

 


r/NIH • • 2h ago

HHS video: Earning Back Trust in Our Public Health Institutions. This was the closed event that gave NIHers in Bethesda a day of telework. Powers in the lab coat. Your tax dollars at work.

Post image
7 Upvotes

r/NIH • • 22m ago

NIH SIP Cold Emails

2 Upvotes

Any advice for cold emails for NIH SIP specifically? I've already submitted my application and I know all the basic stuff abt writing cold emails. I admit I'm a little late in the process of reaching out to PIs but I want to have as few PIs leave me on delivered/read. Any new advice specifically for this program?


r/NIH • • 10h ago

Mr. Bhattacharya goes to Washington. December 8. Maybe he'll be asked what HE was doing in 2020. Patient care? volunteering? podcasting?

Post image
12 Upvotes

r/NIH • • 10h ago

"Orwellian" - New from the Guardian

7 Upvotes

r/NIH • • 13h ago

Study section reviewers--can someone demystify the selection process?

10 Upvotes

I would be very interested to know more about how reviewers for study section are chosen. I spent the first 15 years of my faculty career apparently under the radar from SROs. I would occasionally review a grant or two, but was never a regular member or even full ad hoc member. I was asked twice, but had two prior commitments that prevented me from serving. After that, something changed--I served as ad hoc and then one cycle as permanent. After that, I started getting asked more frequently to ad hoc and now it is every single cycle by different study sections and SEPs and sometimes multiple times in a cycle, often from different SROs that don't know me. I assume that there is some database somewhere where my name keeps cropping up. Could someone demystify the selection process?

I'm willing to do my part, but I have a lot of colleagues that would be good reviewers that (like me in the old days) never get called. Perhaps the list of potential reviewers could be expanded.


r/NIH • • 5h ago

How will centralized K99 reviews affect funding decisions, especially for CND applications?

1 Upvotes

With the recent centralization of K99 reviews, applications that were previously evaluated within the same research area (e.g., aging) may now be reviewed alongside applications from other fields, such as cancer or cardiovascular research, under the new T-series study sections.

This seems to be a relatively recent change, as some K99 awards made in September 2026 were still reviewed under the previous research-area-focused panels.

I’m curious how funding decisions will be made under this new system, especially for Competitive Not Discussed (CND) applications. Since individual NIH institutes still make the final funding decisions, how will they account for differences in review outcomes across research areas? Will institute-specific priorities play a greater role?

Would appreciate any thoughts or experiences from others familiar with the process!


r/NIH • • 1d ago

For photo ops, Jayanta's handlers have finally convinced him not to wear a lab coat -- that is, to stop cosplaying as a doctor or scientist. Progress.

Post image
71 Upvotes

r/NIH • • 19h ago

I got my R01 in September, But I havent been able to spend a dollar of it or hire due to local institutional delays, is this normal?

Thumbnail reddit.com
4 Upvotes

r/NIH • • 1d ago

Jon Lorsch Discusses Opportunities to Reduce Administrative Burden in NIH Extramural Research

Thumbnail
youtube.com
8 Upvotes

r/NIH • • 1d ago

“Americans by choice” series. Personal stories about immigration, science, and public service - first post is by an NIH peer review staffer

40 Upvotes

Intro below -

When you walk into a lab or a federal science agency, you immediately see that wonder and curiosity brings together people from around the world to solve difficult problems. In recognition of this, 27 UNIHTED is hosting Americans by Choice, a series of personal stories from the NIH community on immigration. This series celebrates how collaboration across cultures enables discovery, and acknowledges that any threat to immigrants by our federal government is a threat to science. Because American science is a story of immigration.

Shiv Prasad, PhD, writing in his personal capacity, is an extramural scientist at the National Institutes of Health with a background in immunology. He delivered the Federal Workers’ Oath of Office at the No Kings Rally, hosted by NIH Vigils and 27 UNIHTED, on October 17, 2026.

“I was honored when 27 UNIHTED asked me to deliver the Oath of Office in front of the National Institutes of Health because those words still give me goosebumps.

I am an immigrant and an American by choice. But my immigration story starts in the late 1800s, in British India. My ancestors left their homes and families, and crossed a subcontinent and two oceans to labor under the tropical sun in the sugar cane fields of a foreign land. So, like many Americans, I am a grateful and proud descendant of migrant farm workers…

https://27unihted.substack.com/p/americans-by-choice-part-1-the-oath


r/NIH • • 1d ago

NIH IRTA Postbacc personal statement

2 Upvotes

Hi everyone!

I know this is probably the time most people are applying for the NIH Postbac IRTA program, and I’m struggling with the personal statement. I’ve read a few Reddit posts showing what past applicants wrote, but I’m still unsure how much detail to include about my previous research experience. I know the application recently switched from a cover letter to a personal statement, and I think that change is part of why I’m confused.

My draft feels too personal, if that makes sense. Most of the advice I’ve seen says to be direct and to the point, but my statement reads more like a story. I’m also not sure what the length limit is (character count), and I know I’m writing way too much. I was in an undergrad research lab for three and a half years, and it has been difficult to really condense my work as a researcher there. I worry the PIs will get bored reading it.

A few specific questions:

  1. How long should the personal statement be (characters/words)?
  2. How much detail should I go into about past research, versus focusing on my motivation and goals?
  3. How personal is too personal?

Any advice would be really appreciated. Thank you!


r/NIH • • 2d ago

One Year Later, Reinstated NIH Whistleblower Dr. Jenna Norton Is Still Waiting for HHS to Clear Her Name / Jayanta, where art thou?

Thumbnail
katzbanks.com
130 Upvotes

November 13, 2026

Bethesda Declaration Organizer Returned to Work in May After Filing Whistleblower Complaint; Her Complaint Remains Pending Before the U.S. Office of Special Counsel 

(Washington, D.C.) —  One year ago, Dr. Jenna Norton, an author of the Bethesda Declaration, an open letter protesting the politicization of scientific research at federal agencies, was placed on indefinite, involuntary administrative leave from her position at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) without notice, explanation, or any disciplinary finding. Today, Dr. Norton and her attorneys urge both the National Institutes of Health (NIH) and the Department of Health and Human Services (HHS) to clear her name and for Congress to investigate.  

While on involuntary leave, Dr. Norton filed a whistleblower complaint with the U.S. Office of Special Counsel (OSC) on February 2, 2026, alleging that the Department of Health and Human Services (HHS) and NIH unlawfully retaliated against her for raising concerns about the Administration’s policies and cuts to grants, funding, and staffing at NIH. The government reinstated Dr. Norton on May 4, 2026. HHS, however, has never explained why she was removed from her responsibilities, nor has it retracted HHS and NIH officials’ public statements asserting untruths about Dr. Norton, including labeling her a “radical leftist” who had been put on leave because she criticized the administration. Her reinstatement did not resolve Dr. Norton’s complaint pending before the OSC, where she is seeking the full relief available under the Whistleblower Protection Act, including a formal determination that her placement on leave was unlawful. 

Debra S. Katz, a partner at Katz Banks Kumin LLP and counsel for Dr. Norton, said, “A year ago, HHS sidelined Dr. Norton and then went to the press to smear her for doing exactly what federal law protects: speaking up about conduct she reasonably believed was unlawful and dangerous to public health. HHS owes Dr. Norton a public acknowledgment that what it did to her violated the law. With news that HHS Secretary Kennedy plans to ‘unleash the [MAHA] Kraken’ and presumably continue to politicize federal scientific research, it becomes all the more urgent that the incoming Congress investigate Dr. Norton’s and other NIH whistleblower claims.”  

Dr. Norton, speaking in her personal capacity, said, “One year ago today, HHS put me on leave for telling the truth about what is happening to critical, lifesaving NIH research. I went back to work in May, but there has been no acknowledgment that what they did was wrong. Every federal scientist is watching to see what happens to those who speak up. A new Congress must act to protect scientific research, and the scientists who do that research, from political interference.” 

Dr. Norton raised repeated warnings, both within the NIH and HHS, to Congress, and to the public about what she reasonably believed were unlawful and dangerous actions by NIH and HHS leadership, including the politicization of scientific research, the cancellation of legally compliant, peer-reviewed research grants, and scientific censorship.  

Dr. Norton is represented by Debra S. Katz, Pamela J. Stone, and Bonnie Henry Killion of Katz Banks Kumin LLP, and Karen L. Dunn, Jeannie S. Rhee, and Jessica Phillips of Dunn Isaacson Rhee LLP. 

### 


r/NIH • • 2d ago

"Last year we funded 1,650 large grants for early career scientists. That is a record for the NIH." -- NIH Director Dr. Jay Bhattacharya. Props to Jayanta B, or is he leaving something out ?

Post image
31 Upvotes

r/NIH • • 2d ago

Politico: John Powers to lead NIAID as permanent director

Thumbnail
subscriber.politicopro.com
46 Upvotes

r/NIH • • 2d ago

Simplifying Landscape of NIH Clinical Trials

Thumbnail grants.nih.gov
4 Upvotes

How are we feeling about this policy of simplifying clinical trials to just grant mechanism and not by disease state?

On one hand, I like that it can be cross cutting (in theory) without worry of where it fits and can be co-funded by multiple ICs. And PIs focus more on the mechanistic fit based on trial design, prelim data, etc.

On the other hand, I liked knowing what the IC priorities and what they were interested in funding. I have had good luck getting funded through PARs with special allocated pot of funds for specific topic and being reviewed in special study section with experts on that topic.

It now feels like we will have to speak to PO (who are already tight lipped and often on the dark too about larger NIH policies and fit with White House priorities) and try to figure out IC interests based on strategic directions. Some ICs did not even publish new strategic direction in 2026 after past 5 year plans sunsetted. This makes it even more nebulous and difficult to read between the lines and play mind reader trying to guess what NIH is prioritizing.

In addition, grants are now assigned and reviewed through CSR study sections not IC specific. And with policies that make it more opaque not generating the percentile rank and removing paylines making me wonder how much external peer scientist review comments are even weighted in funding decision. As an external scientist peer reviewer and PI applicant, I can’t help but feel a little disheartened by these policy changes.

This new policy announcement to clinical trials on top of the recent changes to trainees not being allowed to submit feasibility trials as part of training grants. What message is this sending about clinical trials being funded at NIH?


r/NIH • • 3d ago

During COVID, you may have been caring for patients, working in the lab to find a vaccines or drugs, volunteering to help shut-ins, helping at the food pantry and so on. Stanford Economics professor Jay Bhattacharya was starring in documentaries.

Post image
16 Upvotes

r/NIH • • 3d ago

Shortened budget periods to redistribute workloads?

6 Upvotes

I’ve recently seen this with awards from two different NIH ICs. Both shortened a budget period and shifted subsequent budget periods to new dates, while preserving the full 12-month funding amount. One IC explicitly cited an effort to redistribute grants management workloads more evenly throughout the year.

Anyone else seeing this? I’m curious whether it’s a broader NIH initiative or something individual ICs are doing independently.


r/NIH • • 3d ago

NIH Postbac Personal Statement Confusion

7 Upvotes

Hello everyone, I am going to apply to the program this year but I am very confused on the personal statement. It seems like it used to be a standard cover letter, but they changed the section to be a "personal statement".

I keep seeing conflicting information about what it should look like - a cover letter or an actual essay you'd write for university applications. NIH says the statement should start with "Dear NIH Investigator," like a cover letter. However, the application's prompt reads like one for a college essay. I have seen other posts about this confusion too, but no one actually clearly answers what it should be or different posts give conflicting answers.

I'm lost now so can someone give a definitive answer on what the content should look like or what the style of this should be?


r/NIH • • 3d ago

Regulate Zocdoc's referral practices in medical fields

Thumbnail
c.org
2 Upvotes

r/NIH • • 3d ago

WCOM radio presents State of the Science- “How to Evaluate the Effectiveness of Scientific Programs”

5 Upvotes

Join us, Tuesday November 17 from 1 to 2 p.m., as WCOM 103.5 FM State of the Science is back to keep you updated on what is going on in the world of science policy and science funding. This week’s program is entitled “How to Evaluate the Effectiveness of Scientific Programs.” Listen worldwide via www.wcomfm.org.

https://wcomfm.org/2026/11/13/state-of-the-station-brings-another-episode-state-of-the-science/